See also this year's filing and all EDGAR filings for this company.
PDF Report 0001743881_2026_Bridgebio_Pharma_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.5967696890709364, 'aggregate_val': 3012606000, 'exp_sum': 1160136000, 'exp_to_value': {'LiabilitiesCurrent': 287971000, 'LiabilitiesNoncurrent': 17135000, 'remainder_Liabilities': 855030000}} |
Graph
Absolute values for 0001743881, Bridgebio Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 797,749,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 28,077,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,366,000 |
| 3 | remainder_Assets | 104,833,000 |
| 4 | LiabilitiesCurrent | 287,971,000 |
| 5 | LiabilitiesNoncurrent | 17,135,000 |
| 6 | remainder_Liabilities | 2,707,500,000 |
| 7 | CostOfGoodsAndServicesSold | 13,756,312 |
| 8 | SellingGeneralAndAdministrativeExpense | 702,919,923 |
| 9 | ResearchAndDevelopmentExpense | 496,604,638 |
| 10 | remainder_Expenses | 21,659,695 |
| 11 | remainder_Revenues | 372,535,853 |
| 12 | remainder_NetIncome | -325,968,289 |
| 13 | remainder_ComprehensiveNetIncome | 8,991,626 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 936,025,000 |
| 1 | Liabilities | 3,012,606,000 |
| 2 | Expenses | 1,234,940,568 |
| 3 | Revenues | 372,535,853 |
| 4 | StockholdersEquity | -2,076,581,000 |
| 5 | NetIncome | -1,188,373,004 |
| 6 | ComprehensiveNetIncome | -1,183,877,191 |
| 7 | BaseVar | 2,945,533,668 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.89 |
| 9 | EconomicCapitalRatio | 0.722 |
Edgar->Model Mapping
Feature Distribution
Change over Time
